mTORC pathway involved in antiphospholipid sx vasculopathy

mTORC pathway involved in antiphospholipid sx vasculopathy
The mammalian target of rapamycin complex pathway seems to be involved in antiphospholipid syndrome-associated vascular lesions, according to a study published in the July 24 issue of the New England Journal of Medicine.

(HealthDay)—The mammalian target of rapamycin complex (mTORC) pathway seems to be involved in antiphospholipid syndrome-associated vascular lesions, according to a study published in the July 24 issue of the New England Journal of Medicine.

Guillaume Canaud, M.D., Ph.D., from Université Paris Descartes, and colleagues examined the molecular pathways involved in the vasculopathy of antiphospholipid syndrome. Double immunostaining was used to assess pathway activation in mTORC. In addition, the nature of cell proliferation was assessed in the vessels of patients with primary or secondary antiphospholipid syndrome nephropathy.

The researchers found that patients with antiphospholipid syndrome nephropathy exhibited indications of mTORC pathway activation in the of proliferating intrarenal vessels. Immunoglobulin G antibodies from patients with antiphospholipid syndrome stimulated mTORC in cultured through the phosphatidylinositol 3-kinase-AKT pathway. Compared with patients with antiphospholipid antibodies who required transplantation and were not receiving sirolimus, those who were receiving sirolimus had no recurrence of vascular lesions and decreased vascular proliferation on biopsy. Seventy percent of patients treated with sirolimus had a functioning renal allograft at 144 months after transplantation, compared with 11 percent of untreated patients. The of autopsy specimens from patients with catastrophic antiphospholipid syndrome had evidence of mTORC activation.

"Our results suggest that the mTORC pathway is involved in the vascular lesions associated with the ," the authors write.

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Infant cooing, babbling linked to hearing ability

5 hours ago

Infants' vocalizations throughout the first year follow a set of predictable steps from crying and cooing to forming syllables and first words. However, previous research had not addressed how the amount ...

Developing 'tissue chip' to screen neurological toxins

6 hours ago

A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that ...

Gene mutation discovered in blood disorder

10 hours ago

An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells. Studying a family in which ...

Airway muscle-on-a-chip mimics asthma

12 hours ago

The majority of drugs used to treat asthma today are the same ones that were used 50 years ago. New drugs are urgently needed to treat this chronic respiratory disease, which causes nearly 25 million people ...

User comments